CN Patent
CN118480041A — 取代的多环化合物及其药物组合物和用途
Assigned to Shijiazhuang Dikaiwei Pharmaceutical Technology Co ltd · Expires 2024-08-13 · 2y expired
What this patent protects
本发明公开了一种取代的多环化合物及其药物组合物和用途,所述取代的多环化合物如式(I)所示,其中各基团的定义详见说明书,可用于抗流感病毒;
USPTO Abstract
本发明公开了一种取代的多环化合物及其药物组合物和用途,所述取代的多环化合物如式(I)所示,其中各基团的定义详见说明书,可用于抗流感病毒;
Drugs covered by this patent
- Xofluza (BALOXAVIR MARBOXIL) · Roche
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.